- Home
- HAYN vs IMNM Comparison
HAYN vs IMNM Comparison
Compare HAYN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAYN
- IMNM
- Stock Information
- Founded
- HAYN 1912
- IMNM 2006
- Country
- HAYN United States
- IMNM United States
- Employees
- HAYN N/A
- IMNM N/A
- Industry
- HAYN Steel/Iron Ore
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- HAYN Industrials
- IMNM Health Care
- Exchange
- HAYN Nasdaq
- IMNM Nasdaq
- Market Cap
- HAYN 772.3M
- IMNM 747.7M
- IPO Year
- HAYN N/A
- IMNM 2020
- Fundamental
- Price
- HAYN $60.99
- IMNM $9.42
- Analyst Decision
- HAYN Hold
- IMNM Strong Buy
- Analyst Count
- HAYN 2
- IMNM 5
- Target Price
- HAYN N/A
- IMNM $28.60
- AVG Volume (30 Days)
- HAYN 243.4K
- IMNM 756.0K
- Earning Date
- HAYN 11-26-2024
- IMNM 11-13-2024
- Dividend Yield
- HAYN 1.44%
- IMNM N/A
- EPS Growth
- HAYN N/A
- IMNM N/A
- EPS
- HAYN 2.90
- IMNM N/A
- Revenue
- HAYN $614,334,000.00
- IMNM $10,129,000.00
- Revenue This Year
- HAYN $4.57
- IMNM N/A
- Revenue Next Year
- HAYN $2.32
- IMNM N/A
- P/E Ratio
- HAYN $21.04
- IMNM N/A
- Revenue Growth
- HAYN 7.18
- IMNM N/A
- 52 Week Low
- HAYN $47.77
- IMNM $6.93
- 52 Week High
- HAYN $61.01
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- HAYN 68.93
- IMNM 29.22
- Support Level
- HAYN $60.25
- IMNM $8.97
- Resistance Level
- HAYN $60.86
- IMNM $13.52
- Average True Range (ATR)
- HAYN 0.20
- IMNM 0.85
- MACD
- HAYN 0.02
- IMNM -0.30
- Stochastic Oscillator
- HAYN 97.50
- IMNM 9.59
About HAYN Haynes International Inc.
Haynes International Inc is a producer of high-performance nickel and cobalt-based alloys. The company is focused on developing, manufacturing, marketing, and distributing technology and high-performance alloys. The company operates in a single segment: the design, manufacture, marketing, and distribution of technologically advanced, high-performance alloys for use in the aerospace, industrial gas turbine, chemical processing, and other industries Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, China, and other countries.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.